Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953961 · ClinicalTrials.gov registry record · NA
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
A NA study of Carcinoma, Hepatocellular, sponsored by Ochsner Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05953961: Recruiting NA study of Carcinoma, Hepatocellular, sponsored by Ochsner Health System.
NCT05953961 is a NA study of Carcinoma, Hepatocellular that is actively recruiting participants, run by Ochsner Health System. The registered enrollment target is 50 participants, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05953961, a NA study of Carcinoma, Hepatocellular, is actively recruiting participants, sponsored by Ochsner Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who are candidates for both 90-Yittrium Therasphere transarterial radioembolization (90Y) and microwave ablation (MWA). The study will determine whether treatment with 90Y lowers the risk of disease progression within the first year after diagnosis. Participants will be randomized to receive either first cycle 90Y or MWA and then proceed with standard of care.
Primary Outcome
Progression in disease staging according to the Barcelona Clinic Liver Cancer Staging Algorithm
Conditions Studied
Interventions
- DEVICE Therasphere 90Y
- DEVICE Microwave Ablation
Study Locations (1)
Louisiana
- Ochsner Main Campus - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT05953961 shows while recruiting
NCT05953961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 2 interventions - of which Therasphere 90Y is the first listed.
NCT05953961 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05953961 about?
NCT05953961 is a clinical study titled "90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia". This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who are candidates for both 90-Yittrium Therasphere transarterial radioembolization (90Y) and microwave ablation (MWA). The study will determine ...
What is the current status of trial NCT05953961?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-08-08. Estimated completion is 2027-01.
What conditions does trial NCT05953961 study?
This clinical trial studies the following conditions: Carcinoma, Hepatocellular.
What interventions are being tested in trial NCT05953961?
The interventions under investigation include: Therasphere 90Y (DEVICE), Microwave Ablation (DEVICE).
Who is sponsoring clinical trial NCT05953961?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05953961 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Hepatocellular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05953961's enrollment target sits among peer trials
50 19th of 27 higher than 9 of 27 other Carcinoma, Hepatocellular trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carcinoma, Hepatocellular trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Advanced Image Guidance Utilized in Liver Surgery
COMPLETED · NA
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
RECRUITING · Phase 1
-
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI